PE20000646A1 - Terapia de combinacion para la fragilidad musculoesqueletica - Google Patents

Terapia de combinacion para la fragilidad musculoesqueletica

Info

Publication number
PE20000646A1
PE20000646A1 PE1999000528A PE00052899A PE20000646A1 PE 20000646 A1 PE20000646 A1 PE 20000646A1 PE 1999000528 A PE1999000528 A PE 1999000528A PE 00052899 A PE00052899 A PE 00052899A PE 20000646 A1 PE20000646 A1 PE 20000646A1
Authority
PE
Peru
Prior art keywords
oxo
phenyl
combination therapy
tartrate salt
musculoskeletal
Prior art date
Application number
PE1999000528A
Other languages
English (en)
Spanish (es)
Inventor
Hua Zhu Ke
David Duane Thompson
Mei Li
Lydia Codetta Pan
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of PE20000646A1 publication Critical patent/PE20000646A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
PE1999000528A 1998-06-16 1999-06-15 Terapia de combinacion para la fragilidad musculoesqueletica PE20000646A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8946998P 1998-06-16 1998-06-16

Publications (1)

Publication Number Publication Date
PE20000646A1 true PE20000646A1 (es) 2000-08-05

Family

ID=22217825

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1999000528A PE20000646A1 (es) 1998-06-16 1999-06-15 Terapia de combinacion para la fragilidad musculoesqueletica

Country Status (30)

Country Link
EP (1) EP1087764A1 (ru)
JP (1) JP2002518326A (ru)
KR (1) KR20010052852A (ru)
CN (1) CN1301160A (ru)
AP (1) AP9901582A0 (ru)
AR (1) AR018869A1 (ru)
AU (1) AU4054799A (ru)
BG (1) BG105041A (ru)
BR (1) BR9911324A (ru)
CA (1) CA2335134A1 (ru)
CO (1) CO5070587A1 (ru)
EA (1) EA200001186A1 (ru)
GT (1) GT199900087A (ru)
HN (1) HN1999000097A (ru)
HR (1) HRP20000859A2 (ru)
HU (1) HUP0102505A3 (ru)
ID (1) ID27599A (ru)
IL (1) IL138630A0 (ru)
IS (1) IS5691A (ru)
MA (1) MA26652A1 (ru)
NO (1) NO20006312L (ru)
OA (1) OA11505A (ru)
PA (1) PA8475901A1 (ru)
PE (1) PE20000646A1 (ru)
PL (1) PL344981A1 (ru)
SK (1) SK18912000A3 (ru)
TN (1) TNSN99124A1 (ru)
TR (1) TR200003544T2 (ru)
WO (1) WO1999065486A1 (ru)
ZA (1) ZA993975B (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047735A2 (en) * 1999-02-08 2000-08-17 Mcgill University NON-HUMAN TRANSGENIC ANIMAL WHOSE GERM CELLS AND SOMATIC CELLS CONTAIN A KNOCKOUT MUTATION IN DNA ENCODING ORPHAN NUCLEAR RECEPTOR ERRalpha
ES2274854T3 (es) 2000-05-08 2007-06-01 Pfizer Products Inc. Resolucion enzimatica de moduladores selectivos del receptor de estrogeno.
JP2004507502A (ja) 2000-08-30 2004-03-11 ファイザー・プロダクツ・インク 成長ホルモン分泌促進物質のための徐放性製剤
IL145106A0 (en) * 2000-08-30 2002-06-30 Pfizer Prod Inc Intermittent administration of a geowth hormone secretagogue
US7476653B2 (en) 2003-06-18 2009-01-13 Tranzyme Pharma, Inc. Macrocyclic modulators of the ghrelin receptor
WO2006024931A2 (en) * 2004-08-31 2006-03-09 Pfizer Products Inc. Therapeutic combinations comprising a selective estrogen receptor modulator and a selective androgen receptor modulator
CU23558A1 (es) 2006-02-28 2010-07-20 Ct Ingenieria Genetica Biotech Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
JP2010518090A (ja) 2007-02-09 2010-05-27 トランザイム・ファーマ，インコーポレイテッド 大環状グレリン受容体修飾因子およびその使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA51676C2 (ru) * 1995-11-02 2002-12-16 Пфайзер Інк. (-)Цис-6(S)-фенил-5(R)-[4-(2-пирРолидин-1-илетокси)фенил]-5,6,7,8-тетрагидронафталин-2-ол D-тартрат, способ его получения, способы лечения заболеваний поддающихся лечению агонистами эстрогена, и фармацевтическая композиция
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
HN1996000101A (es) * 1996-02-28 1997-06-26 Inc Pfizer Terapia combinada para la osteoporosis

Also Published As

Publication number Publication date
ID27599A (id) 2001-04-12
CO5070587A1 (es) 2001-08-28
JP2002518326A (ja) 2002-06-25
NO20006312D0 (no) 2000-12-12
OA11505A (en) 2004-05-07
ZA993975B (en) 2000-12-15
PL344981A1 (en) 2001-11-19
HUP0102505A3 (en) 2002-12-28
HRP20000859A2 (en) 2001-04-30
GT199900087A (es) 2000-12-07
TNSN99124A1 (fr) 2005-11-10
TR200003544T2 (tr) 2001-04-20
KR20010052852A (ko) 2001-06-25
NO20006312L (no) 2000-12-12
CN1301160A (zh) 2001-06-27
HUP0102505A2 (hu) 2001-11-28
IL138630A0 (en) 2001-10-31
CA2335134A1 (en) 1999-12-23
AR018869A1 (es) 2001-12-12
EP1087764A1 (en) 2001-04-04
BG105041A (en) 2001-08-31
MA26652A1 (fr) 2004-12-20
SK18912000A3 (sk) 2001-10-08
AP9901582A0 (en) 1999-06-30
EA200001186A1 (ru) 2001-06-25
PA8475901A1 (es) 2000-05-24
WO1999065486A1 (en) 1999-12-23
IS5691A (is) 2000-10-27
AU4054799A (en) 2000-01-05
BR9911324A (pt) 2001-04-03
HN1999000097A (es) 1999-11-03

Similar Documents

Publication Publication Date Title
PE20020722A1 (es) Derivados de glucopiranosiloxipirazol como inhibidor del sglt2 humano
ECSP066315A (es) Derivados de la piridazina y su uso como agentes terapéuticos
CO5271691A1 (es) Nuevos compuestos
BG107697A (en) Ep4 receptor selective agonists in the treatment of osteoporosis
PA8493701A1 (es) Compuestos para tratar la obesidad
PA8531001A1 (es) Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti-inflamatorios y analgesicos
MY144897A (en) 2,3,4,9-tetrahydro-1h-carbazole derivatives as crth2 receptor antagonists
BR0015624A (pt) Uso de um composto, composto, composição farmacêutica, e, método de tratamento ou profilaxia de doenças ou condições humanas
DK1317419T3 (da) Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler
ES2146300T3 (es) Utilizacion de composiciones antihelminticas para el tratamiento de infecciones causadas por anoplocephala perfoliata en equidos.
NO20022442L (no) Legemidler for sykdommer i forbindelse med reduksjon i benmasse
CU23241B7 (es) 2-fenil-1-(4(2-aminoetoxi)-benzil)-indol en combinacion con estrogenos
BR0316877A (pt) Derivados de aril-quinazolina/aril-2-amino-fenil metanona que promovem a liberação de hormÈnio da paratireóide
DE60120077D1 (de) Modulatoren des Glucocorticoid-Rezeptors
BRPI0417621A (pt) terapia de combinação contìnua com agonistas seletivos do receptor ep4 de prostaglandina e um estrogênio para o tratamento de estados que se apresentem com baixa massa óssea
PE20000646A1 (es) Terapia de combinacion para la fragilidad musculoesqueletica
MY133503A (en) Selective iglur5 receptor antagonists for the treatment of migrane
PE20000644A1 (es) Combinaciones terapeuticas que comprenden un modulador del receptor de estrogenos selectivo y hormona paratiroidea
PE20030944A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos y procedimientos para su uso
AU2284001A (en) Substituted aminoalkylamide derivatives as antagonists of follicle stimulating hormone
ECSP044961A (es) Acido n-(5-clorosaliciloil)-8-aminocaprilico como agente de suministro oral para fragmentos de hormona paratiroides
PE122699A1 (es) Antagonistas de receptores de vitronectina
BRPI0410050A (pt) método de tratamento ou de profilaxia de distúrbios psicóticos, distúrbios de prejuìzo intelectual ou doenças ou condições nos quais a modulação do receptor alfa7-nicotìnico é benéfica, composição farmacêutica, método de tratamento ou de profilaxia de doenças, uso de um composto, composto, e, método de preparação de um composto
PE20000633A1 (es) Combinaciones terapeuticas para la fragilidad musculoesqueletica
BRPI0407178A (pt) Composição farmacêutica osteogênica

Legal Events

Date Code Title Description
FD Application declared void or lapsed